The Cancer in Young People in Canada/ Cancer Chez les Jeunes au Canada program (CYP-C / CCJC) is a collaborative effort between the C17 Council, the Public Health Agency of Canada (PHAC), and the Canadian Partnership Against Cancer (CPAC). The purpose of CYP-C / CCJC is to contribute to the control of cancer in children and adolescents in Canada by collaborating in the collection, analysis, interpretation and dissemination of Canadian population based surveillance data. This population-based study is carried out at the 17 Canadian pediatric hematology/oncology centres. Data is collected on diagnosis, treatment and short-term (5 year) outcome of children and adolescents less than 19 years of age. For additional information, please see the PHAC website. The CYP-C partners are committed to transparency as an operating principle, and terms of reference are available to stakeholders (Sept 2018).
The Cancer in Young People in Canada (CYP-C) Data Tool provides pan-Canadian surveillance data on children and youth with cancer to inform research and planning for cancer control efforts.
L'outil de données sur le Cancer chez les jeunes au Canada (CCJC) fournit des données de surveillance pancanadiennes sur les enfants et les jeunes atteints de cancer afin d'orienter la recherche et la planification des efforts de lutte contre le cancer.
The Cancer in Young People in Canada report presents in-depth diagnostic, treatment, and outcome data on children under the age of 15 years diagnosed with cancer.
Le rapport Cancer chez les jeunes au Canada présente des données exhaustives sur le diagnostic, le traitement et les issues chez des enfants de moins de 15 ans ayant reçu un diagnostic de cancer.
If you have any questions, please contact:
Randy Barber
C17 Research Manager, CYP-C Surveillance
Randy.Barber@c17.ca